Thursday, November 27, 2014

Meeting in the National Cancer Institute

Members of the Pilot Program had a meeting organized by National Cancer Institute (NCI)*.
     This program provides drugs for pain treatment in patients with active, progressive and advanced diseases.
     Guillermo Cleti (LIF’s Director), Cecilia Selis (LIF’s Technical Director), Patricia Peirotti (LIF’s Quality Assurance Manager) and Ana María Gonzalez (LIF’s Responsible for Drug Safety) participated in a meeting that took place at the National Cancer Institute (NCI)* in Buenos Aires city.
     Daniel Gollan (National Health Vice-Minister) welcomed the present.
     Then, María José Sanchez (ANMAT’s Inspector) gave a lecture about traceability for drugs.
     Finally, Patricia Peirotti gave a lecture about Quality Assurance while Ana María Gonzalez talked about Drug Safety for methadone.
     Pharmacists and physicians from different hospitals under the Pilot Program such as: CEMAR (Rosario), Gastroenterología B. Udaondo, General de Agudos Dr. Tornu, Instituto de Oncología Ángel Roffo, Instituto de Investigaciones Médicas Alfredo Lanari and Dr. Baldomero Sommer attended this meeting.
     Daniel Gollan (National Health Vice-Minister), Federico Kaski (ANMAT Sub-Administrator), Jorge Zarzur (Executive Director of the National Program of Public Production of Medicines, Vaccines and Medical Devices), Graciela Jacob (NCI’s Advisory Committee Member) and Roberto Wenk (NCI’s Advisory Committee Member) also participated in the meeting.

*NCI: is part of the National Health Ministry.
ANMAT: Administración Nacional de Medicamentos, Alimentos y Tecnología Médica. (National Regulatory Agency for medicines, food and medical devices).

No comments: